✦ LIBER ✦

A dose finding study of docetaxel/carboplatin as first-line. Chemotherapy for epithelial ovarian cancer - final results

✍ Scribed by R. Atkinson; P.A. Vasey; R. Coleman; M. Crawford; M. Cruickshank; P. Eggleton; D. Fleming; J. Graham; D. Parkin; J. Paul; N.S. Reed; S.B. Kaye

Book ID: 117123759
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 157 KB
Volume: 70
Category: Article
ISSN: 0020-7292
DOI: 10.1016/s0020-7292(00)81916-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility study comparing docetaxel–ci

Feasibility study comparing docetaxel–cisplatin versus docetaxel–carboplatin as first-line chemotherapy for ovarian cancer

✍ Yukihisa Minagawa; Junzo Kigawa; Yasunobu Kanamori; Hiroaki Itamochi; Naoki Tera 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 92 KB

A dose-finding study of carboplatin–epir

A dose-finding study of carboplatin–epirubicin–docetaxel in advanced epithelial ovarian cancer

✍ O'Neill, V J; Kaye, S B; Reed, N S; Paul, J; Davis, J A; Vasey, P A 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

SCOTROC 2A: Carboplatin followed by doce

SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer

✍ Vasey, P A; Atkinson, R; Osborne, R; Parkin, D; Symonds, R; Paul, J; Lewsley, L; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

SCOTROC 2B: feasibility of carboplatin f

SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer

✍ Clamp, A R; Mäenpää, J; Cruickshank, D; Ledermann, J; Wilkinson, P M; Welch, R; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

654 - Dose finding study of high-dose ep

654 - Dose finding study of high-dose eplrubicln (E) and docetaxel (T) as first line chemotherapy in advanced breast cancer (ABC)

✍ O. Pagani; M. Aapro; G. Martinelli; J. Bauer; M. Borner; D. Crivellari; B. Thürl 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 221 KB

First-line chemotherapy with epidoxorubi

First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients

✍ A Romanini; L Tanganelli; F Carnino; A Fanucchi; R Lionetto; S Pastorino; S Cosi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 86 KB